Beal, M. F. (2001). Experimental models of Parkinson's disease. Nat Rev Neurosci, 2, 325-334.

Betarbet, R., Sherer, T. B., & Greenamyre, J. T. (2002). Animal models of Parkinson's disease. Bioessays, 24, 308-318.

Deumens, R., Blokland, A., & Prickaerts, J. (2002). Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway. Exp Neurol, 175, 303-317.

Hornykiewicz, O. (1993). Parkinson's disease and the adaptive capacity of the nigrostriatal dopamine system: possible neurochemical mechanisms. Adv Neurol, 60, 140-147.

Isacson, O. (1996). On the causes and treatments of Parkinson’s disease. The Parkinson Report, Vol. 17 . Retrieved November 30, 2003, from the Research Reports Index of the National Parkinson Foundation

Lang, A.E., & Lozano, A.M. (1998). Parkinson's disease. First of two parts. N Engl J Med, 339, 1044-1053.

Rajput, A.H., Offord, K.P., Beard, C.M., & Kurland, L.T. (1984). Epidemiology of parkinsonism: incidence, classification, and mortality. Ann Neurol, 16, 278-82.

Schwarting, R.K., & Huston, J.P. (1997). Behavioral and neurochemical dynamics of neurotoxic meso-striatal dopamine lesions. Neurotoxicology,18, 689-708.

Schwarting, R.K.W., & Huston, J.P. (1996). The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Prog Neurobiol, 50, 275-331.

Ungerstedt, U., & Arbuthnott, G.W. (1970). Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res, 24, 485-493.

Zigmond, M.J., & Stricker, E.M. (1984). Parkinson's disease: studies with an animal model. Life Sci, 35, 5-18.